Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
7-Point Dermoscopy ChecklistABSI (Burn Severity)AGEP ScoreAJCC Melanoma StagingALDEN AlgorithmBWH SCC StagingBody Surface Area (BSA)Breslow & Clark MicrostagingCTCAE Skin ToxicityDLQIEASI ScoreGAGS (Acne)HiSCRIGAIHS4Lund-Browder ChartMSK Melanoma NomogramMelanoma Risk ScreeningPASI ScorePOEMRegiSCAR DRESS ValidationRevised Baux ScoreSCORADmPASI
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.

RegiSCAR DRESS Validation

RegiSCAR DRESS Validation: Clinical scoring system for systemic drug hypersensitivity.

Clinical Validation Criteria

Fever ≥ 38.5°C
Enlarged Lymph Nodes (≥ 2 sites)
Eosinophilia (cells/μL)
Internal Organ Involvement

Ready to Validate

Enter the laboratory and clinical findings from the patient evaluation to determine the DRESS validation score.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use

The RegiSCAR scoring system provides a standardized, validated method to classify suspected Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-Induced Hypersensitivity Syndrome (DIHS). Developed by the European RegiSCAR consortium and validated prospectively in a multinational cohort, it is used whenever DRESS enters the differential diagnosis of a severe febrile drug reaction.

Primary Indications

Suspected DRESS presenting 2–8 weeks after drug initiation with widespread rash, fever, and internal organ involvement
Differentiating DRESS from other SCARs: SJS/TEN and AGEP
Differentiating DRESS from viral exanthems (EBV, CMV, HHV-6 primary infection) and hypereosinophilic syndromes
Guiding need for systemic immunosuppression vs. watchful waiting in ambiguous presentations
Research and pharmacovigilance classification of severe drug reactions

When NOT to Use

AGEP — use the EuroSCAR AGEP validation score instead
SJS/TEN — use SCORTEN for mortality prediction; RegiSCAR DRESS criteria do not apply
Simple morbilliform drug eruptions without systemic features — not an appropriate use
As a substitute for clinical monitoring: serial labs are mandatory regardless of score category

Critical Alert

DRESS carries ~10% mortality from fulminant hepatitis, myocarditis, or pneumonitis. Discontinue the culprit drug immediately when DRESS is clinically suspected — do not await a definitive score.

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the ALDEN Algorithm, AGEP Score or the SCORTEN to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Related Dermatology Tools

POEM
Breslow & Clark Microstaging
AJCC Melanoma Staging
Lund-Browder Chart
BWH SCC Staging
PASI Score
Melanoma Risk Screening
CTCAE Skin Toxicity
EASI Score
7-Point Dermoscopy Checklist
Dermatology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.